Eleventh Annual Clinical Sequencing

The implementation of next-generation sequencing has drastically impacted clinical decision-making, but the process for doing so has not been carefully examined nor fully understood. Sequencing data increases our understanding of the biology of cancer and inherited disorders, and has the capacity to enable less invasive methods for prenatal and newborn diagnosis. This session will review the efforts that are underway to standardize and regulate the use of sequence information, and to understand how it will usher in a new era of screening and diagnosis of human diseases.